#AskBQ is BloombergQuint’s daily offering where market experts help investors make the right investment choice in the equity market.
On Tuesday’s episode, Brijesh Singh of StockAxis and Sandeep Jain of Tradeswift Broking gave their views on pharma stocks, IT shares, HEG , GMR Infra and much more.
Watch the full conversation here:
Edited excerpts form the conversation:
Devesh Udasi: I bought 20 shares of HEG at Rs 2,900 with a long-term view. Should I hold or sell?
Sandeep Jain: I would suggest you hold on to the stock. However, you need to be careful when markets correct.
Charanjit Singh: I hold 7,000 shares of GMR Infra at Rs 18. If GMR Airports is listed, will that be positive?
Sandeep Jain: I recommend you to hold on to the stock.
Arpit Maheshwari: Between Sandur Manganese and Maithan Alloys, which is a better bet with a long-term view?
Sandeep Jain: You have selected excellent stocks in the sector. You can buy both the stocks but need to be cautious about liquidity, since they are small-cap stocks. Another stock I like in the sector is MOIL.
Deepak Goyal: I bought 150 shares of Dalmia Bharat Sugar at Rs 102 with a six-month view. Should I hold or sell?
Brijesh Singh: I would suggest you exit the stock since there is no bounceback expected. Rather, you should consider buying IT stocks like NIIT Tech and Tech Mahindra to cover your losses.
Melwyn Monis: I want to invest in Lupin with a one-year view. Please advise.
Sandeep Jain: I prefer IT over pharma stocks. However, if one wants to get into pharma sector, while Lupin is a good bet, I prefer Sun Pharma. One can also, buy Syngene and Ipca Labs.
Sandeep Solanki: I bought 3,000 shares of TBZ at Rs 122 with a long-term view. Should I average at current levels?
Brijesh Singh: I would suggest that you exit the stock as there is no upside seen in the short term and medium term. If you want to stay invested in this sector, I suggest you to invest in PC Jeweller. One can buy PC Jeweller at Rs 325 levels with a a stop-loss of Rs 300 and a target of Rs 380 for short term and Rs 420 for medium term.
Ashwin Mehta: I want to invest in Bombay Dyeing with a six-month view. Please suggest.
Brijesh Singh: One can buy the stock at Rs 250-255 levels with a medium-term view. Keep stop-loss at Rs 245 and a price target of Rs 305 levels.
Shivang Bhatt: I bought 100 shares of Max Financial at Rs 570 with a three-year view. Should I average at current levels?
Sandeep Jain: I would not suggest you average at these levels. Instead, I advise you to switch to other similar stocks such as ICICI Prudential and HDFC Standard Life.
Bhabani Shankar: I bought Voltas at Rs 620 with around two-month view.
Brijesh Singh: One can hold on to the stock with a stop-loss of Rs 600-605 and a target of Rs 660. If you extend your time horizon to six months, the stock can touch Rs 725 levels.
Bharat Bhushan: I bought 1,200 shares of BPCL at Rs 222. Should I hold or book profits?
Sandeep Jain: I suggest you to consider booking some profits and invest in other stocks like Reliance Industries, if you’re inclined to stay within the sector.
Manoj Shukla: I bought 2,100 shares of Rain Industries at Rs 361. Can I hold on to the stock for the next six months?
Brijesh Singh: I recommend you to hold on to the stock. With a stop-loss of Rs 345. I expect the stock to touch Rs 470-480 levels in the next six months.
Manu M: I bought 300 shares of Rallis India at Rs 274 with a four-year view. What should I do?
Sandeep Jain: One can hold on to the stock.
Sandeep Kataria: I bought 500 shares of Dwarikesh Sugar at Rs 51, What should I do?
Brijesh Singh: I suggest you book losses. You could invest in IT stocks to recover your losses.
Ankit Shashtri: I bought shares of KRBL at Rs 480 with a long-term view. What should I do?
Sandeep Jain: I would suggest you hold on to the stock.
Kaushal Singh: I want to invest in Hatsun Agro with a medium-term view. Please suggest.
Brijesh Singh: Avoid the stock at the moment. One can invest in the stock at Rs 695-700 with a short term or medium term. Keep a stop-loss of Rs 6,445 and a target of Rs 775.
Analyst disclosures: both the analysts do not hold any stocks that were discussed today.
Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint’s digital and social media platforms provide views of only SEBI registered investment advisors/analysts.